*Hirohisa Watanabe¹ (1. Department of Neurology, Fujita Health University, School of Medicine)

*Shinsuke Ishigaki¹ (1. Molecular Neuroscience Research Center, Shiga University of Medical Science )

*Akihiro Mouri^1,3, Kazuo Kunisawa¹, Toshitaka Nabeshima^2,3 (1. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Sciences., 2. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Sciences., 3. Japanese Drug Organization of Appropriate Use and Research.)

*Nobuhisa Iwata^1,2, Takaomi C. Saido² (1. Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences Nagasaki University, 2. RIKEN Center for Brain Science)